创新药概念
创新药板块以新分子实体与差异化机制药物研发为核心，覆盖靶向与免疫治疗、ADC、基因与细胞疗法，以及药物发现、临床开发到商业化全链条。板块总市值达 1784.87 billion HKD，24h 涨跌幅 -1.17%，40 个标的中上涨 9 个（占比 22.50%），下跌 28 个（占比 70.00%）。领涨个股为 乐普生物－B (02157)，24h 涨幅 +2.47%。该板块在涨跌参差的走势中回落，尽管龙头股表现更好。保持精选：围绕临床或政策催化事件进行交易；偏好现金充足、处于后期临床阶段的管线，并在走弱时逢低加仓，因为利率和报销信号正在影响估值。
名称 | 最新价 | 涨跌幅 | 最新价 / 涨跌幅 | 走势图 | 价格区间 | 操作 |
|---|---|---|---|---|---|---|
 信达生物－B01801 | HK$89.25¥77.10 | -0.11%-¥0.08 | HK$89.25 -0.11% | ¥76.24¥77.75 | ||
 石药集团01093 | HK$8.48¥7.32 | +2.16%+¥0.15 | HK$8.48 +2.16% | ¥7.16¥7.44 | ||
 百济神州06160 | HK$193.4¥167.0 | -3.15%-¥5.4 | HK$193.4 -3.15% | ¥167.0¥173.1 | ||
 药明康德02359 | HK$156.4¥135.1 | -0.38%-¥0.5 | HK$156.4 -0.38% | ¥134.5¥136.1 | ||
 金斯瑞生物科技01548 | HK$16.68¥14.41 | -0.83%-¥0.12 | HK$16.68 -0.83% | ¥14.30¥14.58 | ||
 康诺亚－B02162 | HK$77.30¥66.78 | -6.07%-¥4.31 | HK$77.30 -6.07% | ¥66.78¥71.70 | ||
 药明生物02269 | HK$38.34¥33.12 | -0.82%-¥0.27 | HK$38.34 -0.82% | ¥33.00¥33.60 | ||
 康方生物09926 | HK$95.40¥82.41 | -3.24%-¥2.76 | HK$95.40 -3.24% | ¥82.15¥85.57 | ||
 晶泰控股02228 | HK$6.92¥5.97 | -3.48%-¥0.21 | HK$6.92 -3.48% | ¥5.91¥6.27 | ||
 三生制药01530 | HK$17.01¥14.69 | -0.70%-¥0.10 | HK$17.01 -0.70% | ¥14.62¥14.80 | ||
 科伦博泰生物－B06990 | HK$502.5¥434.1 | -2.14%-¥9.5 | HK$502.5 -2.14% | ¥431.9¥443.6 | ||
 药明合联02268 | HK$53.05¥45.83 | -2.39%-¥1.12 | HK$53.05 -2.39% | ¥45.48¥47.17 | ||
 荣昌生物09995 | HK$84.55¥73.04 | -1.28%-¥0.95 | HK$84.55 -1.28% | ¥71.96¥74.21 | ||
 中国生物制药01177 | HK$5.07¥4.38 | -0.39%-¥0.01 | HK$5.07 -0.39% | ¥4.34¥4.40 | ||
 翰森制药03692 | HK$32.20¥27.81 | -0.30%-¥0.08 | HK$32.20 -0.30% | ¥27.73¥28.25 | ||
 巨子生物02367 | HK$28.66¥24.75 | -1.30%-¥0.32 | HK$28.66 -1.30% | ¥24.62¥25.64 | ||
 乐普生物－B02157 | HK$4.55¥3.93 | +2.47%+¥0.09 | HK$4.55 +2.47% | ¥3.80¥4.12 | ||
 恒瑞医药01276 | HK$57.20¥49.41 | +0.26%+¥0.12 | HK$57.20 +0.26% | ¥49.11¥49.80 | ||
 康哲药业00867 | HK$12.04¥10.40 | +0.16%+¥0.01 | HK$12.04 +0.16% | ¥10.28¥10.49 | ||
 再鼎医药09688 | HK$14.87¥12.84 | 0.00%¥0.00 | HK$14.87 0.00% | ¥12.68¥12.91 |